Detalhe da pesquisa
1.
Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinoma.
Hepatology
; 75(4): 831-846, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34543483
2.
Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma.
Cancer Immunol Immunother
; 70(2): 377-389, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32761426
3.
Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis.
Hepatology
; 72(3): 906-922, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838741
4.
A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression.
Hepatology
; 70(4): 1214-1230, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30933361
5.
Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection.
Cancer Cell Int
; 20(1): 582, 2020 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33292317
6.
Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence.
J Hepatol
; 71(6): 1152-1163, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31349001
7.
Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection.
Cancer Immunol Immunother
; 68(8): 1223-1233, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31201473
8.
Corrigendum to 'Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence' [J Hepatol 71 (2019) 1152-63].
J Hepatol
; 76(4): 990, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35151501
9.
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma.
J Gastroenterol
; 59(5): 411-423, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461467
10.
Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma.
JAMA Netw Open
; 6(3): e231476, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36867406
11.
Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma.
JAMA Surg
; 157(1): 59-65, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34730772
12.
Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence.
Signal Transduct Target Ther
; 7(1): 24, 2022 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078970
13.
LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2.
Clin Transl Med
; 11(5): e409, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047479
14.
MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3ß/ß-catenin signaling.
NPJ Genom Med
; 5: 15, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32257385